OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant

Trial Profile

OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant

Discontinued
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Zoledronic acid (Primary) ; Cisplatin; Doxorubicin; Etoposide; Ifosfamide; Methotrexate
  • Indications Osteosarcoma
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Acronyms OS 2006
  • Most Recent Events

    • 04 Jan 2016 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 04 Jul 2012 Planned End Date changed to 1 Mar 2014; EudraCT record reports the study will take 9 years to complete.
    • 26 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top